Morrissey Eimear C, Byrne Molly, Casey Bláthín, Casey Dympna, Gillespie Paddy, Hobbins Anna, Lowry Michelle, McCarthy Elizabeth, Newell John, Roshan Davood, Sharma Shikha, Dinneen Sean F
Health Behaviour Change Research Group, School of Psychology, National University of Ireland, Galway, Ireland.
School of Medicine, National University of Ireland, Galway, Ireland.
Pilot Feasibility Stud. 2022 Mar 8;8(1):56. doi: 10.1186/s40814-022-00986-5.
The D1 Now intervention is designed to improve outcomes in young adults living with type 1 diabetes. It consists of three components: an agenda-setting tool, an interactive messaging system and a support worker. The aim of the D1 Now pilot cluster randomised controlled trial (RCT) was to gather and analyse acceptability and feasibility data to allow (1) further refinement of the D1 Now intervention, and (2) determination of the feasibility of evaluating the D1 Now intervention in a future definitive RCT.
A pilot cluster RCT with two intervention arms and a control arm was conducted over 12 months. Quantitative data collection was based on a core outcome set and took place at baseline and 12 months. Semi-structured interviews with participants took place at 6, 9 and 12 months. Fidelity and health economic costings were also assessed.
Four diabetes centres and 57 young adults living with type 1 diabetes took part. 50% of eligible young adults were recruited and total loss to follow-up was 12%. Fidelity, as measured on a study delivery checklist, was good but there were three minor processes that were not delivered as intended in the protocol. Overall, the qualitative data demonstrated that the intervention was considered acceptable and feasible, though this differed across intervention components. The agenda-setting tool and support worker intervention components were acceptable to both young adults and staff, but views on the interactive messaging system were mixed.
Some modifications are required to the D1 Now intervention components and research processes but with these in place progression to a definitive RCT is considered feasible.
ISRCTN (ref: ISRCTN74114336 ).
“D1 Now”干预措施旨在改善1型糖尿病青年患者的治疗效果。它由三个部分组成:一个议程设定工具、一个交互式信息系统和一名支持人员。“D1 Now”试点整群随机对照试验(RCT)的目的是收集和分析可接受性及可行性数据,以便(1)进一步完善“D1 Now”干预措施,以及(2)确定在未来的确定性RCT中评估“D1 Now”干预措施的可行性。
进行了一项为期12个月的试点整群RCT,设有两个干预组和一个对照组。定量数据收集基于一组核心结局指标,在基线和12个月时进行。在6个月、9个月和12个月时对参与者进行半结构化访谈。还评估了保真度和卫生经济成本。
四个糖尿病中心和57名1型糖尿病青年患者参与其中。招募了50%符合条件的青年患者,总失访率为12%。根据研究实施清单衡量,保真度良好,但有三个小流程未按方案预期实施。总体而言,定性数据表明该干预措施被认为是可接受且可行的,不过不同干预组成部分的情况有所不同。议程设定工具和支持人员干预组成部分对青年患者和工作人员来说都是可接受的,但对交互式信息系统的看法不一。
需要对“D1 Now”干预组成部分和研究流程进行一些修改,但进行确定性RCT是可行的。
ISRCTN(参考文献:ISRCTN74114336)